Cantor Fitzgerald Maintains Overweight on AvePoint, Raises Price Target to $13
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Brett Knoblauch maintains an Overweight rating on AvePoint (NASDAQ:AVPT) and raises the price target from $11 to $13.
August 09, 2024 | 3:30 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cantor Fitzgerald analyst Brett Knoblauch maintains an Overweight rating on AvePoint and raises the price target from $11 to $13.
The raised price target and maintained Overweight rating from a reputable analyst are likely to positively impact AvePoint's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100